13 Result: Antitrust
FTC Sues Amazon for Illegally Maintaining Monopoly Power
September 27th, 2023
Amazon’s ongoing pattern of illegal conduct blocks competition, allowing it to wield monopoly power to inflate prices, degrade quality, and stifle innovation for consumers and businesses Washington D.C. / CRWE PRESS RELEASE / September 26, 2. Read more
Intel's Wallet Takes a Hit: €376.36 Million EU Antitrust Fine
September 22nd, 2023
The European Commission has re-imposed a fine of approximately €376.36 million on Intel Corporation (Nasdaq: INTC) for anticompetitive practices in the x86 central processing unit (CPU) market dating back to 2009. These practices involved condit. Read more
Biopharmaceutical Giant Amgen to Settle FTC and State Challenges to its Horizon Therapeutics Acquisition
September 01st, 2023
Amgen will be prohibited from leveraging its drug portfolio to disadvantage rivals and will be required to seek prior approval before acquiring related products Washington D.C. / CRWE PRESS RELEASE / September 1, 2023 - The Federal Tra. Read more
FTC Acts to Prevent Interlocking Directorate Arrangement, Anticompetitive Information Exchange in EQT, Quantum Energy Deal
August 16th, 2023
Agency obtains innovative structural relief that preserves competition in the Appalachian Basin natural gas market following private equity-led deal Washington D.C. / CRWE PRESS RELEASE / August 16, 2023 - The Federal Trade Commission today t. Read more
FTC and DOJ Seek Comment on Draft Merger Guidelines
July 19th, 2023
Proposed guidelines would address the many ways mergers can weaken competition, harming consumers, workers, and businesses Washington D.C. / CRWE PRESS RELEASE / July 19, 2023 - Today, the Federal Trade Commission and the Departm. Read more
Breaking: FTC Seeks More Info on Pfizer's Seagen Merger Plan
July 15th, 2023
Seagen Inc. (Nasdaq: SGEN) and Pfizer Inc. (NYSE: PFE) have encountered a regulatory hurdle in their planned merger. According to a regulatory filing with the SEC, both companies received a Second Request from the Federal Trade Commission (FTC) on Ju. Read more
Commission Order Vacates ALJ Initial Decision and Dismisses Complaint in Case Against Altria and Juul
July 03rd, 2023
Order Clarifies Points of Law in ALJ Initial Decision Washington D.C. / CRWE PRESS RELEASE / July 3, 2023 - On Friday, June 30, 2023, the Federal Trade Commission vacated the Administrative Law Judge’s (ALJ) initial decision&. Read more
President Biden's Economic Vision Pays Off: The Rise of Bidenomics
June 28th, 2023
Bidenomics, the economic vision of President Biden, has proven to be successful in growing the economy from the middle out and bottom up, rather than relying on a top-down approach. The strategy was implemented to address longstanding challenges in t. Read more
FTC Further Expands Inquiry Into Prescription Drug Middlemen Industry Practices
June 08th, 2023
Agency issues order to additional GPO as it examines the impact of vertically integrated PBMs on prescription drug prices and access Washington D.C. / CRWE PRESS RELEASE / June 8, 2023 - As part of its ongoing study on pharmacy be. Read more
FTC Approves Final Order Requiring Mastercard to Stop Blocking the Use of Competing Debit Payment Networks
May 30th, 2023
Washington D.C. / CRWE PRESS RELEASE / May 30, 2023 - Following a public comment period, the Federal Trade Commission finalized a consent order settling charges that Mastercard used illegal business tactics to force merchant. Read more
Statement Regarding the Termination of Boston Scientific Corporation’s Attempted Acquisition of a Majority Stake in M.I. Tech Co., Ltd.
May 24th, 2023
Washington D.C. / CRWE PRESS RELEASE / May 24, 2023 - In response to the announcement that Boston Scientific Corporation and non-vascular stent manufacturer M.I. Tech Co., Ltd. have terminated their $230 million purchase agreement, Federal. Read more
Justice Department Statements on District Court Ruling Enjoining American Airlines and JetBlue’s Northeast Alliance
May 20th, 2023
Washington D.C. / CRWE PRESS RELEASE / May 19, 2023 - Attorney General Merrick B. Garland and Assistant Attorney General Jonathan Kanter for the Justice Department’s Antitrust Division issued the following statements today regarding . Read more
FTC Sues to Block Biopharmaceutical Giant Amgen from Acquisition That Would Entrench Monopoly Drugs Used to Treat Two Serious Illnesses
May 16th, 2023
The $27.8 billion acquisition of Horizon Therapeutics plc would enable Amgen Inc. to stifle competition for thyroid eye disease and chronic refractory gout treatments, the agency says LAS VEGAS, NV / CRWE PRESS RELEASE / May 16, 2023 - The F. Read more
Want To Find Some News?
News By Industries
Recent Post
-
Micron Technology, Jabil, and Birkenstock Earnings Preview: What to Expect
December 15th, 2024Upcoming Earnings: Synopsys, AeroVironment, and nCino in Focus
December 01st, 2024Countdown to Earnings: Salesforce, Marvell Technology, and Okta Take the Stage
December 01st, 2024Fluence Energy, Agilent Technologies, and Woodward Earnings On Deck: A Preview
November 24th, 2024Earnings Preview: Walt Disney, Applied Materials, and Celcuity Take Center Stage
November 11th, 2024
Member Login